IL125700A0 - Use of lipophilic antioxidant compounds to prevent retinoid induced uva-mediated oxidative reactions - Google Patents

Use of lipophilic antioxidant compounds to prevent retinoid induced uva-mediated oxidative reactions

Info

Publication number
IL125700A0
IL125700A0 IL12570097A IL12570097A IL125700A0 IL 125700 A0 IL125700 A0 IL 125700A0 IL 12570097 A IL12570097 A IL 12570097A IL 12570097 A IL12570097 A IL 12570097A IL 125700 A0 IL125700 A0 IL 125700A0
Authority
IL
Israel
Prior art keywords
uva
antioxidant compounds
oxidative reactions
lipophilic antioxidant
mediated oxidative
Prior art date
Application number
IL12570097A
Other languages
English (en)
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of IL125700A0 publication Critical patent/IL125700A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
IL12570097A 1996-12-10 1997-12-08 Use of lipophilic antioxidant compounds to prevent retinoid induced uva-mediated oxidative reactions IL125700A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76278496A 1996-12-10 1996-12-10
PCT/US1997/022441 WO1998025587A1 (en) 1996-12-10 1997-12-08 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions

Publications (1)

Publication Number Publication Date
IL125700A0 true IL125700A0 (en) 1999-04-11

Family

ID=25066031

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12570097A IL125700A0 (en) 1996-12-10 1997-12-08 Use of lipophilic antioxidant compounds to prevent retinoid induced uva-mediated oxidative reactions

Country Status (11)

Country Link
EP (1) EP0914089A1 (enrdf_load_stackoverflow)
JP (1) JP2000505816A (enrdf_load_stackoverflow)
KR (1) KR19990082411A (enrdf_load_stackoverflow)
CN (1) CN1215328A (enrdf_load_stackoverflow)
AU (1) AU5518898A (enrdf_load_stackoverflow)
BR (1) BR9707630A (enrdf_load_stackoverflow)
CA (1) CA2246306A1 (enrdf_load_stackoverflow)
ID (1) ID18520A (enrdf_load_stackoverflow)
IL (1) IL125700A0 (enrdf_load_stackoverflow)
IN (1) IN187969B (enrdf_load_stackoverflow)
WO (1) WO1998025587A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801790B1 (fr) * 1999-12-03 2002-01-18 Fabre Pierre Cosmetique Association retinal et aldehydes, composition cosmetique la contenant, a titre de medicament l'association retinal et aldehydes, et procede de preparation de cette association
DE10012151A1 (de) * 2000-03-13 2001-09-27 Gsf Forschungszentrum Umwelt Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD
JP5728152B2 (ja) * 2008-07-07 2015-06-03 株式会社ファンケル 乾燥リポソーム製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3372843D1 (en) * 1982-05-15 1987-09-10 Beecham Group Plc Skin treatment compositions
JP3280712B2 (ja) * 1992-07-13 2002-05-13 株式会社資生堂 皮膚外用剤
FR2718021B1 (fr) * 1994-04-05 1996-06-28 Fabre Pierre Cosmetique Composition topique à base de rétinal.
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US5747010A (en) * 1996-06-12 1998-05-05 Johnson & Johnson Consumer Products, Inc. Photoprotective lipophilic antioxidant compounds and their use to prevent UVA-mediated lipid peroxidation

Also Published As

Publication number Publication date
EP0914089A1 (en) 1999-05-12
JP2000505816A (ja) 2000-05-16
AU5518898A (en) 1998-07-03
IN187969B (enrdf_load_stackoverflow) 2002-08-03
ID18520A (id) 1998-04-16
CN1215328A (zh) 1999-04-28
WO1998025587A1 (en) 1998-06-18
CA2246306A1 (en) 1998-06-18
BR9707630A (pt) 1999-07-27
KR19990082411A (ko) 1999-11-25

Similar Documents

Publication Publication Date Title
EP0954297A4 (en) USE OF BISPHENOLIC COMPOUNDS FOR TREATING TYPE II DIABETES
EP1007480A4 (en) OXIDATION OF AROMATIC HYDROCARBONS
PL334011A1 (en) Derivative of indane or dihydroindole
GB9511840D0 (en) Catalist monitor
HUP0003292A3 (en) Self-emulsifying formulation for lipophilic compounds
HUP0002486A3 (en) Self-emulsifying formulation for lipophilic compounds
HUP0000759A3 (en) Dosage forms comprising separate portions of r- and s-enantiomers
GB2265086B (en) Skin patches containing skin-whitening agents
EP1005343A4 (en) USE OF CSAIDS AS ANGIOGENESIS INHIBITORS
AU2426995A (en) Alkylation of organic aromatic compounds
IT1283585B1 (it) Apparecchiatura per effettuare reazioni di ossidazione parziale
IL105337A0 (en) Preparation of biphenyl derivative
IL113248A0 (en) Use of alpha - 1c specific compounds
PL347029A1 (en) Reduction of oxidative stress factors
HUP0003517A3 (en) Lipophilic diesters of chelating agents
IL125700A0 (en) Use of lipophilic antioxidant compounds to prevent retinoid induced uva-mediated oxidative reactions
IT1296573B1 (it) Procedimento per l'ossidazione di composti aromatici a idrossiaromatici
GB9623984D0 (en) Gadolinium compounds for use as oil-soluble tracers
AU2926395A (en) Use of benzaldehydes to mark hydrocarbons
GB9512479D0 (en) Substituted benzene derivatives
GB2316645B (en) Preparation of compounds by extrusion
HUP0000483A3 (en) Use of aminoisothiazoles as microbicides
GB9616474D0 (en) 6-aryl-(methyl-or methylidine)-quinol-2-one derivatives as voltage
PL317319A1 (en) Oxidative amonolysis of alkylopyridines
GB9709180D0 (en) Equipment concerning bleeding of fish